EASTMAN CHEMICAL CO (EMN) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings. Insiders were net buyers over the last 90 days ($160.0K bought vs $0 sold). Latest close $62.36 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 6, 2026 · Congress to Nov 16, 2026.
Markel Group — 1 tracked fund hold EMN. See all holders.
Insiders bought on the open market (1 purchase, $160.0K) vs 0 sales ($0). Latest buy: Nov 6, 2026. Insider trading
DuPont de Nemours, Inc. (DD) · DOW INC. (DOW) · ROGERS CORP (ROG) · HEXCEL CORP /DE/ (HXL) · Merck & Co., Inc. (MRK) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Markel Group | 0.04% | 74,950 | HELD Q3 filed Oct 30 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -7.1% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 645 of 8,857 filers |
| Long-only filers among them | 644 |
| Change vs 2026 Q1 | +13 net · 598 entered · 585 exited |
| Shares reported, all filers | 106,509,739 |
| Reported value, all filers | $7.0B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Plastic Materials, Synth Resins & Nonvulcan Elastomers (SIC 2821) |
| Revenue · FY2025 | $8.8B |
| Net income · FY2025 | $474.0M |
| Total assets · FY2025 | $14.9B |
| Shares outstanding | 114,377,421 |
| Market cap (at latest close) | $7.1B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jun 30, 2026.
| Shares short · Oct 15, 2026 | 6,251,948 |
| Share of shares outstanding | 5.47% |
| Days to cover | 4.20 |
Shares short at recent settlements — Jul 31, 2026: 5.3M · Aug 14, 2026: 5.6M · Aug 31, 2026: 5.4M · Sep 15, 2026: 5.8M · Sep 30, 2026: 6.7M · Oct 15, 2026: 6.3M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jun 30, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jun 30, 2026.
1 insider bought on the open market in the last 90 days (1 purchase, $160.0K), against 0 sales by 0 insiders ($0). Latest buy: Nov 6, 2026.
Source: SEC Form 4 filings. Open-market transactions only.
| Latest open-market buy | Transaction price | Price change since disclosure |
|---|---|---|
| McAlindon Julie A. · 2,451 shares on Nov 6, 2026 · filed Nov 10, 2026 | $65.28 | -6.3% (close Nov 11, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Nov 11, 2026). The transaction price is what the insider paid; the price change is on closing prices (dividends excluded).
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | McAlindon Julie A. | SVP, Regions & Chf SupChn Ofcr | Buy | 2,451 | $65.28 | $160.0K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Holt Adrian James | Officer | 3,283 | $234.1K | Aug 4, 2026 | SEC filing |
| May 5, 2026 | Holt Adrian James | Officer | 1,709 | $131.7K | May 5, 2026 | SEC filing |
| Feb 4, 2026 | Killian Christopher Moore | Former Officer | 6,016 | $475.0K | Feb 4, 2026 | SEC filing |
| Mar 3, 2025 | Caveness Michelle H | Officer | 1,147 | $113.0K | Mar 3, 2025 | SEC filing |
| Feb 26, 2025 | Costa Mark J | Officer, Director | 4,834 | $483.8K | Feb 26, 2025 | SEC filing |
| Feb 21, 2025 | McLain William Thomas Jr. | Officer | 1,963 | $198.3K | Feb 21, 2025 | SEC filing |
| Feb 20, 2025 | Holt Adrian James | Officer | 2,037 | $206.1K | Feb 20, 2025 | SEC filing |
| Dec 3, 2024 | Holt Adrian James | Officer | 3,683 | $386.3K | Dec 3, 2024 | SEC filing |
| Dec 2, 2024 | LICH BRAD A | Officer | 36,277 | $3.8M | Dec 2, 2024 | SEC filing |
| Nov 29, 2024 | Costa Mark J | Officer, Director | 18,278 | $1.9M | Nov 29, 2024 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | Vanguard Portfolio Management | SC 13G | 7,670,415 | 6.7% | Mar 31, 2026 | SEC filing |
| Apr 29, 2026 | Vanguard Capital Management | SC 13G | 5,974,518 | 5.2% | Mar 31, 2026 | SEC filing |
| Apr 24, 2026 | BlackRock, Inc. | SC 13G/A | 15,745,661 | 13.8% | Mar 31, 2026 | SEC filing |
| Mar 26, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Dec 4, 2025 | BlackRock, Inc. | SC 13G/A | 13,598,433 | 11.9% | Nov 30, 2025 | SEC filing |
| Aug 13, 2025 | Capital Research Global Investors | SC 13G/A | 4,246,293 | 3.7% | Jun 30, 2025 | SEC filing |
| Aug 5, 2025 | Franklin Resources, Inc. | SC 13G/A | 4,493,013 | 3.9% | Jun 30, 2025 | SEC filing |
| May 9, 2025 | Franklin Resources, Inc. | SC 13G | 5,831,455 | 5.1% | Mar 31, 2025 | SEC filing |
| Feb 13, 2025 | Capital Research Global Investors | SC 13G | 5,886,564 | 5.1% | Dec 31, 2024 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Plastic Materials, Synth Resins & Nonvulcan Elastomers (SIC 2821). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 461 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Taxation/Internal Revenue Code (273), Energy/Nuclear (209), Trade (domestic/foreign) (198).
Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Insiders
· Insider Net Buying — Last 90 days: more insider buy transactions than sell transactions
Financial Screens
· Dividend Growth — Dividends raised for more than 10 years
· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
· Shareholder Yield — Cash returned through dividends and buybacks
· Earnings Stability — Small earnings swings and almost no loss years
Key figures
· Dividend Growth — Dividend per share: 3.33 · Dividend yield: 4.9% · Straight dividend years: 17 · 10-yr dividend growth: 76.2%
· Cash Flow (FCF) — Latest FCF: $424.0M · FCF yield: 5.4% · Positive FCF years: 3
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.67 · Operating cash flow: $970.0M · Net income: $474.0M
· Shareholder Yield — Shareholder yield: 4.9% · of which dividends: 4.9% · of which buybacks: 0.0%
· Earnings Stability — Earnings variation (CV): 0.30 · Loss years (of 10): 0 · Latest net income: $474.0M
· Insider Net Buying — Buy txns: 1 · Sell txns: 0 · Buy value: $160.0K · Latest buy: Nov 6, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2025 Q3, ranked #2 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Share count tripled (3x) | 1 | 0.0% | -12.9% | -8.2% | -4.7% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold EMN — ranked by lift, the co-holding pattern described in Methodology: DuPont de Nemours, Inc. (DD) · DOW INC. (DOW) · ROGERS CORP (ROG) · HEXCEL CORP /DE/ (HXL) · Merck & Co., Inc. (MRK) · LINDE PLC (LIN) · ELI LILLY & Co (LLY) · PROCTER & GAMBLE Co (PG).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Nov 12, 2026 | 1.01 Entry into a Material Definitive Agreement · 8.01 Other Events · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 29, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 20, 2026 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · 8.01 Other Events · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
DuPont de Nemours, Inc. (DD) · Track Record: how the signals scored · Practice timing on EMN
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.